- Home
- IMTE vs THAR Comparison
IMTE vs THAR Comparison
Compare IMTE & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- THAR
- Stock Information
- Founded
- IMTE 2008
- THAR 2017
- Country
- IMTE Malaysia
- THAR United States
- Employees
- IMTE N/A
- THAR N/A
- Industry
- IMTE Consumer Electronics/Appliances
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- THAR Health Care
- Exchange
- IMTE Nasdaq
- THAR Nasdaq
- Market Cap
- IMTE 2.6M
- THAR 2.8M
- IPO Year
- IMTE N/A
- THAR 2022
- Fundamental
- Price
- IMTE $1.18
- THAR $2.35
- Analyst Decision
- IMTE
- THAR
- Analyst Count
- IMTE 0
- THAR 0
- Target Price
- IMTE N/A
- THAR N/A
- AVG Volume (30 Days)
- IMTE 3.9K
- THAR 33.0K
- Earning Date
- IMTE 10-22-2024
- THAR 11-06-2024
- Dividend Yield
- IMTE N/A
- THAR N/A
- EPS Growth
- IMTE N/A
- THAR N/A
- EPS
- IMTE N/A
- THAR N/A
- Revenue
- IMTE N/A
- THAR N/A
- Revenue This Year
- IMTE N/A
- THAR N/A
- Revenue Next Year
- IMTE N/A
- THAR N/A
- P/E Ratio
- IMTE N/A
- THAR N/A
- Revenue Growth
- IMTE 174.26
- THAR N/A
- 52 Week Low
- IMTE $1.02
- THAR $1.84
- 52 Week High
- IMTE $4.57
- THAR $142.50
- Technical
- Relative Strength Index (RSI)
- IMTE 43.58
- THAR 48.39
- Support Level
- IMTE $1.17
- THAR $1.89
- Resistance Level
- IMTE $1.38
- THAR $2.05
- Average True Range (ATR)
- IMTE 0.09
- THAR 0.23
- MACD
- IMTE 0.00
- THAR 0.04
- Stochastic Oscillator
- IMTE 37.50
- THAR 60.95
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the development, sale and distribution of autostereoscopic 3D displays, conversion equipment, software and technology solutions, and others, Sales of air-filter products, provision of consultancy services, and Sales of Halal products.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.